Please assess the completion status of the following clinical trial:

Trial Title: Nebulized and Intravenous Colistin in Ventilator Associated-pneumonia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria~* Age older than 18 yr~* Invasive mechanical ventilation for more than 48 h Tracheostomized patients receiving intermittent mechanical ventilation can be included~* VAP caused by Gram-negative MDR bacteria resistant to all β-lactams and fluoroquinolones~Exclusion criteria~* Extrapulmonary Gram-negative MDR infection requiring intravenous colimycin~* VAP associated with bacteremia requiring combined treatment by nebulized and intravenous colimycin~* Hypersensitivity to colistimethate, colistin base, polymyxins and/or their excipients~* Porphyria~* Severe hypoxemia defined as PaO2 / FiO2\< 100; if veno-venous ECMO is initiated, the patient can be included~* Severe brain injury (initial Glasgow coma score \< 8) during the first 7 days before randomization~* Myasthenia~* cystic fibrosis~* Refusal to participate in the study~* Participation in any clinical study of a therapeutic investigational product within 30 days prior to the first day of inclusion~* No affiliation to social health insurance~* Patient under guardianship~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Experimental group (Type: EXPERIMENTAL): Patients receive simultaneously nebulized colimycin every 8 h and intravenous placebo administered once, twice or 3 times per day according to renal function
- Control group (Type: ACTIVE_COMPARATOR): Patients receive simultaneously intravenous colimycin administered once, twice or 3 times per day according to function renal and nebulized placebo every 8 h

Based on this trial design, predict the completion outcome and termination type (if applicable).